Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.

Saved in:
Bibliographic Details
Title: Correction: Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers.
Authors: Bevers LAH; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. Lisanne.Bevers@radboudumc.nl., Kamphuis AEM; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., van der Wekken-Pas LCW; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Leisegang R; Clinical Pharmacology, Paediatric Centre of Excellence, Gilead Sciences, Dublin, Ireland., Burger DM; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Colbers A; Department of Pharmacy (route 864), Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2024 May; Vol. 63 (5), pp. 729-730.
Publication Type: Published Erratum
Journal Info: Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1926
DOI:10.1007/s40262-024-01378-z